BioDelivery Sciences International, Inc. (BDSI): Price and Financial Metrics

BioDelivery Sciences International, Inc. (BDSI)

Today's Latest Price: $4.93 USD

0.31 (6.71%)

Updated May 22 4:00pm

Add BDSI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

BDSI Stock Summary

  • The price/operating cash flow metric for Biodelivery Sciences International Inc is higher than 94.17% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, Biodelivery Sciences International Inc is reporting a growth rate of -165.42%; that's higher than merely 9.92% of US stocks.
  • Revenue growth over the past 12 months for Biodelivery Sciences International Inc comes in at 102.56%, a number that bests 94.64% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to BDSI, based on their financial statements, market capitalization, and price volatility, are RXN, XPO, WWE, SF, and HX.
  • BDSI's SEC filings can be seen here. And to visit Biodelivery Sciences International Inc's official web site, go to
BDSI Daily Price Range
BDSI 52-Week Price Range

BDSI Stock Price Chart More Charts

BDSI Price/Volume Stats

Current price $4.93 52-week high $7.21
Prev. close $4.62 52-week low $2.85
Day low $4.56 Volume 748,200
Day high $4.95 Avg. volume 1,097,846
50-day MA $4.16 Dividend yield N/A
200-day MA $5.04 Market Cap 492.53M

BioDelivery Sciences International, Inc. (BDSI) Company Bio

BioDelivery Sciences International, Inc. engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company was founded in 1997 and is based in Raleigh, North Carolina.

BDSI Latest News Stream

Event/TimeNews Detail
Loading, please wait...

BDSI Latest Social Stream

Loading social stream, please wait...

View Full BDSI Social Stream

Latest BDSI News From Around the Web

Below are the latest news stories about Biodelivery Sciences International Inc that investors may wish to consider to help them evaluate BDSI as an investment opportunity.

BioDelivery Sciences International (BDSI) Beats Q1 Earnings and Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 400.00% and 15.33%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 7, 2020

BioDelivery Sciences Reports Strong Q1 2020 Results

First Quarter Total Company Net Sales Increased 94% versus Prior Year to $38.3 Million First Quarter BELBUCA® Net Sales Increased 79% versus Prior Year to $33.5 Million.

Yahoo | May 7, 2020

BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy?

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | April 30, 2020

BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020

RALEIGH, N.C., April 28, 2020 -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with.

Yahoo | April 28, 2020

Edited Transcript of BDSI earnings conference call or presentation 12-Mar-20 8:30pm GMT

Q4 2019 BioDelivery Sciences International Inc Earnings Call

Yahoo | March 25, 2020

Read More 'BDSI' Stories Here

BDSI Price Returns

1-mo 13.07%
3-mo -3.52%
6-mo -25.42%
1-year 12.30%
3-year 105.42%
5-year -37.99%
YTD -21.99%
2019 70.81%
2018 25.42%
2017 68.57%
2016 -63.47%
2015 -60.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9009 seconds.